Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. scores highest on Nitro (79) and lowest on Earnings (28). Its PosiPenta is 47.63 out of 100, around the middle of similar companies.
On the Penta Grid this week, Kiora Pharmaceuticals, Inc. is Grid #322 of 837 in the Healthcare sector in United States, and Grid #2,150 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. | 47.63 | 44 | 28 | 79 | 57 | 30 |
| Citius Pharmaceuticals, Inc. | 35.76 | 49 | 35 | 16 | 43 | 36 |
| DataMEDS AI, Inc. | 33.03 | 0 | 2 | 15 | 97 | 51 |
| Phio Pharmaceuticals Corp. | 43.11 | 42 | 51 | 20 | 57 | 46 |
| Intensity Therapeutics, Inc. | 31.25 | 37 | 37 | 11 | 45 | 26 |
| Ensysce Biosciences, Inc. | 29.78 | 0 | 53 | 29 | 27 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.98 |
| P/B ratio | 0.63 |
EEarnings
| Trailing EPS | ₹-233.00 |
| Forward EPS | ₹-211.21 |
NNitro
| Price | 227.32 |
| 52-week high | 275.62 |
| 52-week low | 167.17 |
| Fall from 52-week high | 17.5% |
TTorque
| Return on equity (ROE) | -56.37% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | -0.21 |
| Market cap | ₹100 Cr |
| Insider holding | 8.91% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Kiora Pharmaceuticals, Inc.'s PosiPenta score?
Kiora Pharmaceuticals, Inc.'s PosiPenta is 47.63 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Kiora Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Kiora Pharmaceuticals, Inc. is Grid #322 of 837 in the Healthcare sector in United States, and Grid #2,150 of 4,000 in United States.
Which PosiPenta pillar is strongest for Kiora Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 79 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Kiora Pharmaceuticals, Inc.?
Earnings (growth), with a score of 28 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.